[Problems of use trials of long-acting tranquilizers in acute psychiatric syndromes].
D000208:Acute Disease; D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D005260:Female; D005476:Fluphenazine / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D010880:Piperidines / Q000008:administration & dosage / Q000627:therapeutic use; D011618:Psychotic Disorders / Q000188:drug therapy*; D013449:Sulfonamides / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D014150:Antipsychotic Agents; D010880:Piperidines; D013449:Sulfonamides; D014149:Tranquilizing Agents; D005476:Fluphenazine
Problémes posés par les essais d'emploi des neuroleptiques à action prolongée (N.A.P.) dans les syndromes psychiatriques aigus.